Artelo Biosciences (ARTL) 10-Q2024 Q1 Quarterly report

Filed: 13 May 24, 9:17am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accidental, advocated, adware, alleviate, amortize, amortized, ascertain, atopic, attack, attain, branch, CB, Chevron, Chinese, Committee, Court, cyberattack, cybersecurity, deference, dermatologic, destruction, doctrine, dynamic, elude, encryption, engineering, expansion, externally, Extortion, finite, Florida, forecasted, hardware, heightened, incident, increasingly, incremental, landlord, loan, longstanding, malware, military, mobile, neurological, nonclinical, Nonmonetary, Norway, Note, noted, notifying, offline, online, opportunistically, ordinary, outsource, outsourced, persistence, phishing, prevalent, privacy, ransomware, remedial, repriced, repurchase, retaliation, safeguard, sensitive, server, sheet, shield, Similarly, software, sophisticated, sophistication, staffing, staggered, subcontract, Supreme, table, tackle, telecommunication, theft, threat, thwart, translated, translation, transparency, turn, unanticipated, undermine, unlawful, vulnerable, worsening

Removed: aftermath, Budget, CECL, disposition, FASB, foresee, marginally, materialize, regime, repayable

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ARTL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Artelo Biosciences, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory D. Gorgas, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 13, 2024

/s/ Gregory D. Gorgas

Gregory D. Gorgas

President, Chief Executive Officer,

Chief Financial Officer,

Treasurer and Director (Principal Executive Officer,

Principal Financial Officer and

Principal Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.